These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3492264)

  • 1. Mythylation of human HLA-D/DR genes: derangement in chronic lymphocytic leukemia.
    Tobe H; Ruether BA; Jerry LM; Tamaoki T
    Cancer Biochem Biophys; 1986 Oct; 8(4):313-26. PubMed ID: 3492264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of correlation between hypomethylation and expression of the HLA-DR alpha gene.
    Gambari R; Del Senno L; Barbieri R; Buzzoni D; Gustafsson K; Giacomini P; Natali PG
    Eur J Immunol; 1986 Apr; 16(4):365-9. PubMed ID: 3457706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
    Guy K; Meehan RR; Dewar AE; Larhammar D
    Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HLA-DR by a human monocyte cell line is under transcriptional control.
    Peterlin BM; Gonwa TA; Stobo JD
    J Mol Cell Immunol; 1984; 1(3):191-200. PubMed ID: 6443852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA polymorphism of the class II genes in DR4 cells.
    So A; Bodmer J
    Dis Markers; 1986 Jun; 4(1-2):165-72. PubMed ID: 2898313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies.
    Foroni L; Catovsky D; Rabbitts TH; Luzzatto L
    Mol Biol Med; 1984 Feb; 2(1):63-79. PubMed ID: 6439975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive and induced expression of the individual HLA-DR beta and alpha chain loci in different cell types.
    Berdoz J; Gorski J; Termijtelen AM; Dayer JM; Irlé C; Schendel D; Mach B
    J Immunol; 1987 Aug; 139(4):1336-41. PubMed ID: 3112231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of the HLA-DR genes in various melanoma cell lines treated with interferon-gamma: methylation of the HLA-DR alpha gene in these lines is not correlated with its expression.
    Carrington MN; Chedid M; Ting JP; Ward FE
    Hum Immunol; 1987 Feb; 18(2):151-61. PubMed ID: 3104241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Southern blot analysis of HLA class II beta genes in relation to HLA-D, DR specificities.
    Otani F; Okuda M; Kashiwagi N
    Transplant Proc; 1987 Feb; 19(1 Pt 1):817-21. PubMed ID: 3824495
    [No Abstract]   [Full Text] [Related]  

  • 12. Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.
    Foa R; Migone N; Saitta M; Fierro MT; Giubellino MC; Lusso P; Cordero di Montezemolo L; Miniero R; Lauria F
    J Clin Invest; 1984 Nov; 74(5):1756-63. PubMed ID: 6438157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen presentation in an HLA-DR-restricted fashion by B-cell chronic lymphocytic leukemia cells.
    Yasukawa M; Shiroguchi T; Inatsuki A; Kobayashi Y
    Blood; 1988 Jul; 72(1):102-8. PubMed ID: 2455565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of HLA-DR antigens on leukaemic cells.
    Newman RA; Greaves MF
    Clin Exp Immunol; 1982 Oct; 50(1):41-50. PubMed ID: 6959750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation and expression of HLA-DR alpha.
    Reitz MS; Mann DL; Eiden M; Trainor CD; Clarke MF
    Mol Cell Biol; 1984 May; 4(5):890-7. PubMed ID: 6328275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation patterns of HLA-DR alpha genes in six mononuclear cell lines.
    Wang Y; Peterlin BM
    Immunogenetics; 1986; 24(5):298-303. PubMed ID: 3023235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia.
    Corcoran M; Parker A; Orchard J; Davis Z; Wirtz M; Schmitz OJ; Oscier D
    Haematologica; 2005 Aug; 90(8):1078-88. PubMed ID: 16079107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of human LIM-HOX gene, hLH-2, in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
    Wu HK; Minden MD
    Biochem Biophys Res Commun; 1997 Apr; 233(3):806-12. PubMed ID: 9168938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective expression of DR antigens in chronic lymphocytic leukemia.
    Cassol S; Campbell L; Hesse L; Muzik H; Ruether B; Jerry LM
    Oncodev Biol Med; 1982; 3(2-3):233-49. PubMed ID: 6181487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.